Ping Liao

21PUBLICATIONS
90CO-AUTHORS
Molecular targetsHaematologyEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 06, 2026
Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.

|Mar 04, 2024
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).

Jai N Patel, Chen Jiang, Kouros Owzar

|Feb 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.

Sharon P Shriver, Devon Adams, Brittany Avin McKelvey

|Jan 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer

|Jun 28, 2023
Pharmacogenomic Analyses Implicate B Cell Developmental Status and <i>MKL1</i> as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy.

George W Small, Farida S Akhtari, Adrian J Green

|May 27, 2023
<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients.

Ricardo D Gonzalez, George W Small, Adrian J Green

Pageof 4

Frequent Collaborators

3 joint publications

Todd C Knepper

3 joint publications

George W Small

3 joint publications

Ricardo D Gonzalez

3 joint publications

David M Reif